High MYC protein expression in primary colon cancer was also predictive of an inferior response to anti‐EGFR monoclonal antibodies plus FOLFIRI (a polychemotherapy regimen based on 5FU and irinotecan) [113]. Here, MYC is linked to malignant colon neoplasm.